Dhanuka Laboratories Limited, a prominent player in the Indian pharmaceutical industry, is headquartered in New Delhi, India. Founded in 1983, the company has established itself as a leader in the development and manufacturing of a diverse range of pharmaceutical products, including formulations and active pharmaceutical ingredients (APIs). Dhanuka Laboratories is renowned for its commitment to quality and innovation, offering unique formulations that cater to various therapeutic segments. With a strong presence in both domestic and international markets, the company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. Dhanuka's dedication to research and development ensures that it remains at the forefront of the pharmaceutical sector, delivering effective solutions that meet the evolving needs of healthcare professionals and patients alike.
How does Dhanuka Laboratories Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Dhanuka Laboratories Limited's score of 14 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Dhanuka Laboratories Limited, headquartered in India, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Dhanuka Laboratories may not have established formal commitments to reduce carbon emissions or may not publicly disclose such information. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate climate impact. However, without specific emissions data or commitments, it is challenging to assess Dhanuka Laboratories' position in this evolving landscape. As the company moves forward, establishing clear climate commitments and reporting on emissions could enhance its sustainability profile and align with industry standards.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Dhanuka Laboratories Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.